methylphenidate has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 4 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fatigue scores fell significantly during methylphenidate intake in comparison with baseline (mean difference: -0." | 9.12 | Does methylphenidate reduce the symptoms of chronic fatigue syndrome? ( Blockmans, D; Bobbaers, H; Persoons, P; Van Houdenhove, B, 2006) |
| "Fatigue scores fell significantly during methylphenidate intake in comparison with baseline (mean difference: -0." | 5.12 | Does methylphenidate reduce the symptoms of chronic fatigue syndrome? ( Blockmans, D; Bobbaers, H; Persoons, P; Van Houdenhove, B, 2006) |
| "Treatment with methylphenidate resulted in complete resolution of symptoms in two patients and significant improvement in the other two." | 1.29 | Consideration of narcolepsy in the differential diagnosis of chronic fatigue syndrome. ( Ambrogetti, A; Olson, LG, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blockmans, D | 2 |
| Persoons, P | 2 |
| Van Houdenhove, B | 1 |
| Bobbaers, H | 1 |
| Valdizán Usón, JR | 1 |
| Idiazábal Alecha, MA | 1 |
| Ambrogetti, A | 1 |
| Olson, LG | 1 |
1 review available for methylphenidate and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Diagnostic and treatment challenges of chronic fatigue syndrome: role of immediate-release methylphenidate.
Topics: Central Nervous System Stimulants; Delayed-Action Preparations; Fatigue Syndrome, Chronic; Humans; M | 2008 |
2 trials available for methylphenidate and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Long-term methylphenidate intake in chronic fatigue syndrome.
Topics: Activities of Daily Living; Adult; Cross-Over Studies; Dopamine Uptake Inhibitors; Dose-Response Rel | 2016 |
Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
Topics: Adult; Affect; Attention; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method | 2006 |
1 other study available for methylphenidate and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Consideration of narcolepsy in the differential diagnosis of chronic fatigue syndrome.
Topics: Adolescent; Diagnosis, Differential; Fatigue Syndrome, Chronic; Female; Humans; Male; Methylphenidat | 1994 |